US Companion Diagnostics (CDx) Development Market Advancements in Molecular Diagnostics and Biomarker-Based Testing
The growing adoption of precision medicine has significantly changed the approach to cancer diagnosis and treatment. Advanced technologies such as oncology companion diagnostics, molecular diagnostics, and in vitro companion diagnostics are enabling healthcare providers to identify specific biomarkers, select targeted therapies, and improve patient outcomes. These diagnostic solutions are...
0 Kommentare 0 Geteilt 33 Ansichten 0 Bewertungen